06/20
Headlines

Richard Atkins

Richard Atkins is a senior contributor at Tech Insider covering online media, online travel, and video games. Richard has been with Tech Insider covering companies in these industries since 2011 and has authored numerous industry reports, including "Internet Video: Field of Dreams or Nightmare on Elm Street," "The Next Leg of Online Travel," and "Pwned: How Casual Games Changed The Gaming Landscape." Atkins was recognized as the No. 2 stock picker and earnings estimator in the 2011 Financial Times / StarMine Internet & Catalog Retail category and was ranked in the 2010 Wall Street Journal "Best On The Street" for the Leisure Goods & Services category.

Gilead Sciences GILD NASDAQ:GILD

Consumer Goods Active Stocks: Tesla Motors Inc (NASDAQ:TSLA), General Motors Company (NYSE:GM), Coca-Cola Company (NYSE:KO), Ford Motor Company (NYSE:F)

Richard Atkins02 mins

Tesla Motors Inc. (NASDAQ:TSLA) the electric vehicle maker co-founded by Elon Musk, plans to use only raw materials sourced in North America for its proposed $5 billion U.S. battery factory. Tesla Motors Inc (NASDAQ:TSLA) stock performance was 4.09% in last session and finished the day at $216.97. Traded volume was 7.37million shares in the last…

Read More

Healthcare Decliners: Escalon Medical (NASDAQ:ESMC), CorMedix Inc. (NYSEMKT:CRMD), Ocera Therapeutics Inc (NASDAQ:OCRX), Marina Biotech (OTCMKTS:MRNA)

Richard Atkins02 mins

Escalon Medical Corp. (NASDAQ:ESMC) trades at a significant discount to its peer group as the lack of investor (and analyst) following results in the successful “shrink to grow” strategy being ignored. The company is now a pure play with no debt, cash that represents ~20% of the market cap, overlooked tax assets and a significantly…

Read More

Bearish Stocks at NASDAQ: Conatus Pharmaceuticals (NASDAQ:CNAT), Metabolix (NASDAQ:MBLX), Clovis Oncology (NASDAQ:CLVS), Oculus Innovative Sciences (NASDAQ:OCLS)

Richard Atkins02 mins

On March 27, 2014, Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) issued a press release announcing its financial results for the quarter and year ended December 31, 2013. Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) stock performance was -15.63% in last session and finished the day at $8.42. Traded volume was 1.28 million shares in the last session and the average…

Read More